Keyword: cancer

News

Genentech Returns Cancer Drug Rights to NewLink

16.06.2017 - US biotechnology group Genentech, part of Roche, is handing back rights to NewLink Genetics’ IDO inhibitor GDC-0919 (navoximod), an investigational cancer treatment. Genentech...

News

Glythera Launches ADC Project

12.06.2017 - UK biotech Glythera has launched a project to develop next-generation antibody drug conjugates (ADCs) for difficult-to-treat tumors, backed by funding of £1 million from government...

News

J&J Loses Latest Cancer Claim Lawsuit

09.05.2017 - US healthcare giant Johnson & Johnson (J&J) has said it will appeal the verdict of a jury in St. Louis, Missouri, ordering the company to pay more than $110 million in damages to a...

Plant Construction & Process Technology

Bioelectronic Medicines: A New Type of Personalization

27.04.2017 - Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...

News

FDA Warns on Illegal Cancer Treatments

27.04.2017 - The US Food and Drug Administration (FDA) has sent warning letters to 14 US-based companies it accuses of illegally selling more than 65 products fraudulently claiming to prevent...

News

FDA Drug Approvals up Sharply in Q1

24.04.2017 - After a major slowdown in 2016, new drug approvals by the US Food and Drug Administration rose sharply in the first quarter of 2017, according to a report by EP Vantage. Up to mid...

News

BMS and Apexigen Link on Lung Cancer

21.04.2017 - US pharmaceutical companies Bristol-Myers Squibb and Apexigen are collaborating to test a combination of their respective drugs to treat patients with advanced solid tumors...

News

J&J Wins Fourth Cancer Claim Lawsuit

08.03.2017 - After losing three earlier lawsuits alleging that its talc powder caused ovarian cancer – which cost it nearly $200 million in damages – US healthcare giant Johnson & Johnson (J&J)...